Please assess the completion status of the following clinical trial:

Trial Title: Hong Kong and Taiwan HM3 PMS

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~- All patients at the participating sites that are determined to meet the HM3 commercially approved labelling indication and have a planned HM3 implant are eligible to participate in this PMS. Assessment for eligibility criteria is based on medical records of the site and interview with a candidate patient.~Exclusion Criteria: None

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- HeartMate 3™ left ventricular assist system (HM3 LVAS) (Type: EXPERIMENTAL): Patients will be implanted with the HM3 LVAS

Based on this trial design, predict the completion outcome and termination type (if applicable).